Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition

Ranjit K. Goudar, Jeremy N. Rich, Mark D. Hjelmeland et al.|Molecular Cancer Therapeutics|2005

Cited by 245